nodes	percent_of_prediction	percent_of_DWPC	metapath
Enalapril—SLC22A7—Fluorouracil—urinary bladder cancer	0.146	0.22	CbGbCtD
Enalapril—ABCB1—Mitomycin—urinary bladder cancer	0.112	0.169	CbGbCtD
Enalapril—SLC22A7—Methotrexate—urinary bladder cancer	0.0805	0.121	CbGbCtD
Enalapril—SLCO1A2—Methotrexate—urinary bladder cancer	0.0564	0.0851	CbGbCtD
Enalapril—CYP3A4—Thiotepa—urinary bladder cancer	0.051	0.077	CbGbCtD
Enalapril—SLC22A8—Methotrexate—urinary bladder cancer	0.0491	0.0741	CbGbCtD
Enalapril—SLC22A6—Methotrexate—urinary bladder cancer	0.0342	0.0516	CbGbCtD
Enalapril—ABCB1—Gemcitabine—urinary bladder cancer	0.0323	0.0488	CbGbCtD
Enalapril—ABCB1—Cisplatin—urinary bladder cancer	0.0235	0.0354	CbGbCtD
Enalapril—ABCB1—Etoposide—urinary bladder cancer	0.0231	0.0348	CbGbCtD
Enalapril—ABCB1—Doxorubicin—urinary bladder cancer	0.0157	0.0238	CbGbCtD
Enalapril—ABCB1—Methotrexate—urinary bladder cancer	0.0152	0.023	CbGbCtD
Enalapril—CYP3A4—Etoposide—urinary bladder cancer	0.0138	0.0209	CbGbCtD
Enalapril—CYP3A4—Doxorubicin—urinary bladder cancer	0.00943	0.0142	CbGbCtD
Enalapril—ACE—umbilical vein—urinary bladder cancer	0.00924	0.14	CbGeAlD
Enalapril—SLC22A8—urine—urinary bladder cancer	0.00748	0.113	CbGeAlD
Enalapril—ACE—urine—urinary bladder cancer	0.00745	0.113	CbGeAlD
Enalapril—CYP3A4—urine—urinary bladder cancer	0.00371	0.0562	CbGeAlD
Enalapril—Aspartame—TRPV1—urinary bladder cancer	0.00321	0.385	CrCbGaD
Enalapril—Captopril—MMP9—urinary bladder cancer	0.00318	0.383	CrCbGaD
Enalapril—SLC22A7—renal system—urinary bladder cancer	0.00317	0.048	CbGeAlD
Enalapril—SLC15A1—epithelium—urinary bladder cancer	0.00274	0.0416	CbGeAlD
Enalapril—SLC22A8—prostate gland—urinary bladder cancer	0.00268	0.0407	CbGeAlD
Enalapril—ACE—prostate gland—urinary bladder cancer	0.00268	0.0406	CbGeAlD
Enalapril—SLC15A1—renal system—urinary bladder cancer	0.00254	0.0386	CbGeAlD
Enalapril—ACE—seminal vesicle—urinary bladder cancer	0.00226	0.0343	CbGeAlD
Enalapril—ACE—epithelium—urinary bladder cancer	0.00197	0.0298	CbGeAlD
Enalapril—SLCO1A2—renal system—urinary bladder cancer	0.00192	0.0291	CbGeAlD
Enalapril—ACE—smooth muscle tissue—urinary bladder cancer	0.00189	0.0287	CbGeAlD
Enalapril—SLC15A1—vagina—urinary bladder cancer	0.00184	0.0279	CbGeAlD
Enalapril—SLC22A8—renal system—urinary bladder cancer	0.00183	0.0277	CbGeAlD
Enalapril—ACE—renal system—urinary bladder cancer	0.00182	0.0277	CbGeAlD
Enalapril—ACE—urethra—urinary bladder cancer	0.00179	0.0272	CbGeAlD
Enalapril—ACE—female reproductive system—urinary bladder cancer	0.00146	0.0221	CbGeAlD
Enalapril—Benazepril—MTHFR—urinary bladder cancer	0.00128	0.154	CrCbGaD
Enalapril—ABCB1—prostate gland—urinary bladder cancer	0.000942	0.0143	CbGeAlD
Enalapril—CYP3A4—renal system—urinary bladder cancer	0.000907	0.0138	CbGeAlD
Enalapril—ACE—lymph node—urinary bladder cancer	0.000854	0.013	CbGeAlD
Enalapril—ABCB1—seminal vesicle—urinary bladder cancer	0.000797	0.0121	CbGeAlD
Enalapril—CYP3A4—female reproductive system—urinary bladder cancer	0.000726	0.011	CbGeAlD
Enalapril—ABCB1—epithelium—urinary bladder cancer	0.000692	0.0105	CbGeAlD
Enalapril—Nateglinide—PPARG—urinary bladder cancer	0.000654	0.0786	CrCbGaD
Enalapril—ABCB1—renal system—urinary bladder cancer	0.000642	0.00973	CbGeAlD
Enalapril—ABCB1—urethra—urinary bladder cancer	0.000631	0.00956	CbGeAlD
Enalapril—ABCB1—female reproductive system—urinary bladder cancer	0.000514	0.0078	CbGeAlD
Enalapril—ABCB1—vagina—urinary bladder cancer	0.000465	0.00705	CbGeAlD
Enalapril—ABCB1—lymph node—urinary bladder cancer	0.000301	0.00456	CbGeAlD
Enalapril—ABCB1—Codeine and Morphine Metabolism—UGT2B7—urinary bladder cancer	0.000268	0.0768	CbGpPWpGaD
Enalapril—Rash—Thiotepa—urinary bladder cancer	0.000205	0.00079	CcSEcCtD
Enalapril—Bronchitis—Doxorubicin—urinary bladder cancer	0.000205	0.00079	CcSEcCtD
Enalapril—Dermatitis—Thiotepa—urinary bladder cancer	0.000205	0.00079	CcSEcCtD
Enalapril—Agranulocytosis—Methotrexate—urinary bladder cancer	0.000205	0.000789	CcSEcCtD
Enalapril—Headache—Thiotepa—urinary bladder cancer	0.000204	0.000785	CcSEcCtD
Enalapril—Stevens-Johnson syndrome—Epirubicin—urinary bladder cancer	0.000204	0.000785	CcSEcCtD
Enalapril—Decreased appetite—Etoposide—urinary bladder cancer	0.000203	0.000783	CcSEcCtD
Enalapril—Pancytopenia—Doxorubicin—urinary bladder cancer	0.000202	0.00078	CcSEcCtD
Enalapril—Renal failure—Epirubicin—urinary bladder cancer	0.000202	0.000778	CcSEcCtD
Enalapril—Body temperature increased—Cisplatin—urinary bladder cancer	0.000202	0.000777	CcSEcCtD
Enalapril—Fatigue—Etoposide—urinary bladder cancer	0.000201	0.000776	CcSEcCtD
Enalapril—Neuropathy peripheral—Epirubicin—urinary bladder cancer	0.000201	0.000776	CcSEcCtD
Enalapril—Stomatitis—Epirubicin—urinary bladder cancer	0.0002	0.000771	CcSEcCtD
Enalapril—Jaundice—Epirubicin—urinary bladder cancer	0.0002	0.000771	CcSEcCtD
Enalapril—Constipation—Etoposide—urinary bladder cancer	0.0002	0.00077	CcSEcCtD
Enalapril—Urinary tract infection—Epirubicin—urinary bladder cancer	0.0002	0.000769	CcSEcCtD
Enalapril—Conjunctivitis—Epirubicin—urinary bladder cancer	0.0002	0.000769	CcSEcCtD
Enalapril—Dysuria—Doxorubicin—urinary bladder cancer	0.000199	0.000768	CcSEcCtD
Enalapril—Neutropenia—Doxorubicin—urinary bladder cancer	0.000199	0.000768	CcSEcCtD
Enalapril—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000198	0.000764	CcSEcCtD
Enalapril—Upper respiratory tract infection—Doxorubicin—urinary bladder cancer	0.000198	0.000763	CcSEcCtD
Enalapril—Hepatitis—Methotrexate—urinary bladder cancer	0.000197	0.000759	CcSEcCtD
Enalapril—Pollakiuria—Doxorubicin—urinary bladder cancer	0.000197	0.000759	CcSEcCtD
Enalapril—Asthenia—Gemcitabine—urinary bladder cancer	0.000196	0.000757	CcSEcCtD
Enalapril—Pharyngitis—Methotrexate—urinary bladder cancer	0.000196	0.000753	CcSEcCtD
Enalapril—Photosensitivity reaction—Doxorubicin—urinary bladder cancer	0.000195	0.00075	CcSEcCtD
Enalapril—Epistaxis—Epirubicin—urinary bladder cancer	0.000194	0.000746	CcSEcCtD
Enalapril—Pruritus—Gemcitabine—urinary bladder cancer	0.000194	0.000746	CcSEcCtD
Enalapril—Nausea—Thiotepa—urinary bladder cancer	0.000193	0.000745	CcSEcCtD
Enalapril—Sinusitis—Epirubicin—urinary bladder cancer	0.000193	0.000743	CcSEcCtD
Enalapril—Feeling abnormal—Etoposide—urinary bladder cancer	0.000193	0.000742	CcSEcCtD
Enalapril—Hyperglycaemia—Doxorubicin—urinary bladder cancer	0.000192	0.000741	CcSEcCtD
Enalapril—Agranulocytosis—Epirubicin—urinary bladder cancer	0.000192	0.000739	CcSEcCtD
Enalapril—Pneumonia—Doxorubicin—urinary bladder cancer	0.000191	0.000737	CcSEcCtD
Enalapril—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000191	0.000736	CcSEcCtD
Enalapril—Pruritus—Fluorouracil—urinary bladder cancer	0.00019	0.000734	CcSEcCtD
Enalapril—Visual impairment—Methotrexate—urinary bladder cancer	0.00019	0.000732	CcSEcCtD
Enalapril—Stevens-Johnson syndrome—Doxorubicin—urinary bladder cancer	0.000188	0.000726	CcSEcCtD
Enalapril—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000188	0.000724	CcSEcCtD
Enalapril—Bradycardia—Epirubicin—urinary bladder cancer	0.000188	0.000723	CcSEcCtD
Enalapril—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000187	0.000722	CcSEcCtD
Enalapril—Renal failure—Doxorubicin—urinary bladder cancer	0.000187	0.00072	CcSEcCtD
Enalapril—Erythema multiforme—Methotrexate—urinary bladder cancer	0.000186	0.000718	CcSEcCtD
Enalapril—Neuropathy peripheral—Doxorubicin—urinary bladder cancer	0.000186	0.000718	CcSEcCtD
Enalapril—Urticaria—Etoposide—urinary bladder cancer	0.000186	0.000715	CcSEcCtD
Enalapril—Stomatitis—Doxorubicin—urinary bladder cancer	0.000185	0.000714	CcSEcCtD
Enalapril—Jaundice—Doxorubicin—urinary bladder cancer	0.000185	0.000714	CcSEcCtD
Enalapril—Abdominal pain—Etoposide—urinary bladder cancer	0.000185	0.000712	CcSEcCtD
Enalapril—Body temperature increased—Etoposide—urinary bladder cancer	0.000185	0.000712	CcSEcCtD
Enalapril—Urinary tract infection—Doxorubicin—urinary bladder cancer	0.000185	0.000712	CcSEcCtD
Enalapril—Conjunctivitis—Doxorubicin—urinary bladder cancer	0.000185	0.000712	CcSEcCtD
Enalapril—Hepatitis—Epirubicin—urinary bladder cancer	0.000184	0.00071	CcSEcCtD
Enalapril—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000184	0.000709	CcSEcCtD
Enalapril—Tinnitus—Methotrexate—urinary bladder cancer	0.000184	0.000708	CcSEcCtD
Enalapril—Asthenia—Cisplatin—urinary bladder cancer	0.000183	0.000705	CcSEcCtD
Enalapril—Pharyngitis—Epirubicin—urinary bladder cancer	0.000183	0.000705	CcSEcCtD
Enalapril—Epistaxis—Doxorubicin—urinary bladder cancer	0.000179	0.000691	CcSEcCtD
Enalapril—SLC22A7—Fluoropyrimidine Activity—TYMP—urinary bladder cancer	0.000179	0.0513	CbGpPWpGaD
Enalapril—Sinusitis—Doxorubicin—urinary bladder cancer	0.000178	0.000687	CcSEcCtD
Enalapril—Dizziness—Fluorouracil—urinary bladder cancer	0.000178	0.000686	CcSEcCtD
Enalapril—Visual impairment—Epirubicin—urinary bladder cancer	0.000178	0.000685	CcSEcCtD
Enalapril—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.000177	0.000683	CcSEcCtD
Enalapril—Diarrhoea—Cisplatin—urinary bladder cancer	0.000175	0.000673	CcSEcCtD
Enalapril—Erythema multiforme—Epirubicin—urinary bladder cancer	0.000174	0.000672	CcSEcCtD
Enalapril—Alopecia—Methotrexate—urinary bladder cancer	0.000174	0.000671	CcSEcCtD
Enalapril—Vomiting—Gemcitabine—urinary bladder cancer	0.000174	0.00067	CcSEcCtD
Enalapril—Bradycardia—Doxorubicin—urinary bladder cancer	0.000174	0.000669	CcSEcCtD
Enalapril—Rash—Gemcitabine—urinary bladder cancer	0.000173	0.000665	CcSEcCtD
Enalapril—Dermatitis—Gemcitabine—urinary bladder cancer	0.000172	0.000664	CcSEcCtD
Enalapril—Hypersensitivity—Etoposide—urinary bladder cancer	0.000172	0.000663	CcSEcCtD
Enalapril—Tinnitus—Epirubicin—urinary bladder cancer	0.000172	0.000662	CcSEcCtD
Enalapril—Erythema—Methotrexate—urinary bladder cancer	0.000172	0.000661	CcSEcCtD
Enalapril—Headache—Gemcitabine—urinary bladder cancer	0.000171	0.000661	CcSEcCtD
Enalapril—Flushing—Epirubicin—urinary bladder cancer	0.000171	0.000659	CcSEcCtD
Enalapril—Vomiting—Fluorouracil—urinary bladder cancer	0.000171	0.000659	CcSEcCtD
Enalapril—Hepatitis—Doxorubicin—urinary bladder cancer	0.000171	0.000657	CcSEcCtD
Enalapril—Rash—Fluorouracil—urinary bladder cancer	0.00017	0.000654	CcSEcCtD
Enalapril—Dermatitis—Fluorouracil—urinary bladder cancer	0.00017	0.000653	CcSEcCtD
Enalapril—Pharyngitis—Doxorubicin—urinary bladder cancer	0.000169	0.000652	CcSEcCtD
Enalapril—Headache—Fluorouracil—urinary bladder cancer	0.000169	0.00065	CcSEcCtD
Enalapril—Dysgeusia—Methotrexate—urinary bladder cancer	0.000168	0.000647	CcSEcCtD
Enalapril—Asthenia—Etoposide—urinary bladder cancer	0.000168	0.000646	CcSEcCtD
Enalapril—Back pain—Methotrexate—urinary bladder cancer	0.000166	0.000639	CcSEcCtD
Enalapril—Pruritus—Etoposide—urinary bladder cancer	0.000165	0.000637	CcSEcCtD
Enalapril—CYP3A4—Codeine and Morphine Metabolism—UGT2B7—urinary bladder cancer	0.000165	0.0473	CbGpPWpGaD
Enalapril—Arrhythmia—Epirubicin—urinary bladder cancer	0.000165	0.000635	CcSEcCtD
Enalapril—Visual impairment—Doxorubicin—urinary bladder cancer	0.000164	0.000634	CcSEcCtD
Enalapril—Alopecia—Epirubicin—urinary bladder cancer	0.000163	0.000628	CcSEcCtD
Enalapril—Nausea—Gemcitabine—urinary bladder cancer	0.000163	0.000626	CcSEcCtD
Enalapril—Vomiting—Cisplatin—urinary bladder cancer	0.000162	0.000625	CcSEcCtD
Enalapril—Vision blurred—Methotrexate—urinary bladder cancer	0.000162	0.000623	CcSEcCtD
Enalapril—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.000161	0.000622	CcSEcCtD
Enalapril—Rash—Cisplatin—urinary bladder cancer	0.000161	0.00062	CcSEcCtD
Enalapril—Dermatitis—Cisplatin—urinary bladder cancer	0.000161	0.000619	CcSEcCtD
Enalapril—Erythema—Epirubicin—urinary bladder cancer	0.000161	0.000618	CcSEcCtD
Enalapril—Diarrhoea—Etoposide—urinary bladder cancer	0.00016	0.000616	CcSEcCtD
Enalapril—Nausea—Fluorouracil—urinary bladder cancer	0.00016	0.000616	CcSEcCtD
Enalapril—Tinnitus—Doxorubicin—urinary bladder cancer	0.000159	0.000613	CcSEcCtD
Enalapril—Anaemia—Methotrexate—urinary bladder cancer	0.000159	0.000611	CcSEcCtD
Enalapril—Flushing—Doxorubicin—urinary bladder cancer	0.000158	0.00061	CcSEcCtD
Enalapril—Flatulence—Epirubicin—urinary bladder cancer	0.000158	0.000609	CcSEcCtD
Enalapril—Tension—Epirubicin—urinary bladder cancer	0.000158	0.000607	CcSEcCtD
Enalapril—Dysgeusia—Epirubicin—urinary bladder cancer	0.000157	0.000606	CcSEcCtD
Enalapril—ACE—Peptide hormone metabolism—CDX2—urinary bladder cancer	0.000156	0.0449	CbGpPWpGaD
Enalapril—Nervousness—Epirubicin—urinary bladder cancer	0.000156	0.000601	CcSEcCtD
Enalapril—Back pain—Epirubicin—urinary bladder cancer	0.000155	0.000598	CcSEcCtD
Enalapril—Dizziness—Etoposide—urinary bladder cancer	0.000155	0.000595	CcSEcCtD
Enalapril—Muscle spasms—Epirubicin—urinary bladder cancer	0.000154	0.000595	CcSEcCtD
Enalapril—Vertigo—Methotrexate—urinary bladder cancer	0.000154	0.000594	CcSEcCtD
Enalapril—Leukopenia—Methotrexate—urinary bladder cancer	0.000154	0.000592	CcSEcCtD
Enalapril—Arrhythmia—Doxorubicin—urinary bladder cancer	0.000152	0.000587	CcSEcCtD
Enalapril—Nausea—Cisplatin—urinary bladder cancer	0.000152	0.000584	CcSEcCtD
Enalapril—Vision blurred—Epirubicin—urinary bladder cancer	0.000151	0.000583	CcSEcCtD
Enalapril—Alopecia—Doxorubicin—urinary bladder cancer	0.000151	0.000581	CcSEcCtD
Enalapril—Cough—Methotrexate—urinary bladder cancer	0.00015	0.000577	CcSEcCtD
Enalapril—Vomiting—Etoposide—urinary bladder cancer	0.000149	0.000573	CcSEcCtD
Enalapril—Erythema—Doxorubicin—urinary bladder cancer	0.000149	0.000572	CcSEcCtD
Enalapril—Anaemia—Epirubicin—urinary bladder cancer	0.000148	0.000572	CcSEcCtD
Enalapril—Agitation—Epirubicin—urinary bladder cancer	0.000148	0.000568	CcSEcCtD
Enalapril—Rash—Etoposide—urinary bladder cancer	0.000147	0.000568	CcSEcCtD
Enalapril—Dermatitis—Etoposide—urinary bladder cancer	0.000147	0.000567	CcSEcCtD
Enalapril—Headache—Etoposide—urinary bladder cancer	0.000146	0.000564	CcSEcCtD
Enalapril—Flatulence—Doxorubicin—urinary bladder cancer	0.000146	0.000564	CcSEcCtD
Enalapril—Myalgia—Methotrexate—urinary bladder cancer	0.000146	0.000563	CcSEcCtD
Enalapril—Arthralgia—Methotrexate—urinary bladder cancer	0.000146	0.000563	CcSEcCtD
Enalapril—Chest pain—Methotrexate—urinary bladder cancer	0.000146	0.000563	CcSEcCtD
Enalapril—Tension—Doxorubicin—urinary bladder cancer	0.000146	0.000562	CcSEcCtD
Enalapril—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000145	0.00056	CcSEcCtD
Enalapril—Discomfort—Methotrexate—urinary bladder cancer	0.000144	0.000556	CcSEcCtD
Enalapril—Nervousness—Doxorubicin—urinary bladder cancer	0.000144	0.000556	CcSEcCtD
Enalapril—Vertigo—Epirubicin—urinary bladder cancer	0.000144	0.000556	CcSEcCtD
Enalapril—Syncope—Epirubicin—urinary bladder cancer	0.000144	0.000555	CcSEcCtD
Enalapril—Leukopenia—Epirubicin—urinary bladder cancer	0.000144	0.000554	CcSEcCtD
Enalapril—Back pain—Doxorubicin—urinary bladder cancer	0.000144	0.000554	CcSEcCtD
Enalapril—Muscle spasms—Doxorubicin—urinary bladder cancer	0.000143	0.00055	CcSEcCtD
Enalapril—Palpitations—Epirubicin—urinary bladder cancer	0.000142	0.000547	CcSEcCtD
Enalapril—Confusional state—Methotrexate—urinary bladder cancer	0.000141	0.000544	CcSEcCtD
Enalapril—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000141	0.000544	CcSEcCtD
Enalapril—Cough—Epirubicin—urinary bladder cancer	0.00014	0.00054	CcSEcCtD
Enalapril—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.00014	0.000539	CcSEcCtD
Enalapril—Vision blurred—Doxorubicin—urinary bladder cancer	0.00014	0.000539	CcSEcCtD
Enalapril—SLC22A7—Fluoropyrimidine Activity—RRM2—urinary bladder cancer	0.000139	0.04	CbGpPWpGaD
Enalapril—Nausea—Etoposide—urinary bladder cancer	0.000139	0.000535	CcSEcCtD
Enalapril—Anaemia—Doxorubicin—urinary bladder cancer	0.000137	0.000529	CcSEcCtD
Enalapril—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000137	0.000528	CcSEcCtD
Enalapril—Chest pain—Epirubicin—urinary bladder cancer	0.000137	0.000527	CcSEcCtD
Enalapril—Myalgia—Epirubicin—urinary bladder cancer	0.000137	0.000527	CcSEcCtD
Enalapril—Arthralgia—Epirubicin—urinary bladder cancer	0.000137	0.000527	CcSEcCtD
Enalapril—Agitation—Doxorubicin—urinary bladder cancer	0.000136	0.000526	CcSEcCtD
Enalapril—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000135	0.000521	CcSEcCtD
Enalapril—Discomfort—Epirubicin—urinary bladder cancer	0.000135	0.00052	CcSEcCtD
Enalapril—Dry mouth—Epirubicin—urinary bladder cancer	0.000134	0.000515	CcSEcCtD
Enalapril—Vertigo—Doxorubicin—urinary bladder cancer	0.000133	0.000514	CcSEcCtD
Enalapril—Anorexia—Methotrexate—urinary bladder cancer	0.000133	0.000514	CcSEcCtD
Enalapril—Syncope—Doxorubicin—urinary bladder cancer	0.000133	0.000513	CcSEcCtD
Enalapril—Leukopenia—Doxorubicin—urinary bladder cancer	0.000133	0.000512	CcSEcCtD
Enalapril—Confusional state—Epirubicin—urinary bladder cancer	0.000132	0.000509	CcSEcCtD
Enalapril—Palpitations—Doxorubicin—urinary bladder cancer	0.000131	0.000506	CcSEcCtD
Enalapril—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000131	0.000505	CcSEcCtD
Enalapril—Oedema—Epirubicin—urinary bladder cancer	0.000131	0.000505	CcSEcCtD
Enalapril—Hypotension—Methotrexate—urinary bladder cancer	0.000131	0.000504	CcSEcCtD
Enalapril—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000131	0.000503	CcSEcCtD
Enalapril—Cough—Doxorubicin—urinary bladder cancer	0.00013	0.000499	CcSEcCtD
Enalapril—Shock—Epirubicin—urinary bladder cancer	0.000129	0.000497	CcSEcCtD
Enalapril—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000128	0.000494	CcSEcCtD
Enalapril—Tachycardia—Epirubicin—urinary bladder cancer	0.000128	0.000493	CcSEcCtD
Enalapril—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000128	0.000491	CcSEcCtD
Enalapril—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000127	0.000488	CcSEcCtD
Enalapril—Insomnia—Methotrexate—urinary bladder cancer	0.000127	0.000488	CcSEcCtD
Enalapril—Chest pain—Doxorubicin—urinary bladder cancer	0.000126	0.000487	CcSEcCtD
Enalapril—Myalgia—Doxorubicin—urinary bladder cancer	0.000126	0.000487	CcSEcCtD
Enalapril—Arthralgia—Doxorubicin—urinary bladder cancer	0.000126	0.000487	CcSEcCtD
Enalapril—Paraesthesia—Methotrexate—urinary bladder cancer	0.000126	0.000484	CcSEcCtD
Enalapril—Discomfort—Doxorubicin—urinary bladder cancer	0.000125	0.000481	CcSEcCtD
Enalapril—Anorexia—Epirubicin—urinary bladder cancer	0.000125	0.000481	CcSEcCtD
Enalapril—Dyspnoea—Methotrexate—urinary bladder cancer	0.000125	0.000481	CcSEcCtD
Enalapril—Somnolence—Methotrexate—urinary bladder cancer	0.000124	0.00048	CcSEcCtD
Enalapril—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC14A2—urinary bladder cancer	0.000124	0.0357	CbGpPWpGaD
Enalapril—Dry mouth—Doxorubicin—urinary bladder cancer	0.000124	0.000476	CcSEcCtD
Enalapril—Dyspepsia—Methotrexate—urinary bladder cancer	0.000123	0.000475	CcSEcCtD
Enalapril—Hypotension—Epirubicin—urinary bladder cancer	0.000122	0.000472	CcSEcCtD
Enalapril—Confusional state—Doxorubicin—urinary bladder cancer	0.000122	0.000471	CcSEcCtD
Enalapril—Decreased appetite—Methotrexate—urinary bladder cancer	0.000122	0.000469	CcSEcCtD
Enalapril—Oedema—Doxorubicin—urinary bladder cancer	0.000121	0.000467	CcSEcCtD
Enalapril—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000121	0.000467	CcSEcCtD
Enalapril—Fatigue—Methotrexate—urinary bladder cancer	0.000121	0.000465	CcSEcCtD
Enalapril—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000119	0.00046	CcSEcCtD
Enalapril—Shock—Doxorubicin—urinary bladder cancer	0.000119	0.00046	CcSEcCtD
Enalapril—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000119	0.000457	CcSEcCtD
Enalapril—Insomnia—Epirubicin—urinary bladder cancer	0.000118	0.000457	CcSEcCtD
Enalapril—Tachycardia—Doxorubicin—urinary bladder cancer	0.000118	0.000456	CcSEcCtD
Enalapril—Paraesthesia—Epirubicin—urinary bladder cancer	0.000118	0.000453	CcSEcCtD
Enalapril—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000117	0.000452	CcSEcCtD
Enalapril—Dyspnoea—Epirubicin—urinary bladder cancer	0.000117	0.00045	CcSEcCtD
Enalapril—Somnolence—Epirubicin—urinary bladder cancer	0.000116	0.000449	CcSEcCtD
Enalapril—Anorexia—Doxorubicin—urinary bladder cancer	0.000116	0.000445	CcSEcCtD
Enalapril—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000115	0.000444	CcSEcCtD
Enalapril—Dyspepsia—Epirubicin—urinary bladder cancer	0.000115	0.000444	CcSEcCtD
Enalapril—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000114	0.000441	CcSEcCtD
Enalapril—Decreased appetite—Epirubicin—urinary bladder cancer	0.000114	0.000439	CcSEcCtD
Enalapril—Hypotension—Doxorubicin—urinary bladder cancer	0.000113	0.000436	CcSEcCtD
Enalapril—Fatigue—Epirubicin—urinary bladder cancer	0.000113	0.000435	CcSEcCtD
Enalapril—Constipation—Epirubicin—urinary bladder cancer	0.000112	0.000432	CcSEcCtD
Enalapril—Urticaria—Methotrexate—urinary bladder cancer	0.000111	0.000428	CcSEcCtD
Enalapril—Abdominal pain—Methotrexate—urinary bladder cancer	0.000111	0.000426	CcSEcCtD
Enalapril—Body temperature increased—Methotrexate—urinary bladder cancer	0.000111	0.000426	CcSEcCtD
Enalapril—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.00011	0.000426	CcSEcCtD
Enalapril—Insomnia—Doxorubicin—urinary bladder cancer	0.00011	0.000422	CcSEcCtD
Enalapril—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000109	0.000419	CcSEcCtD
Enalapril—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000108	0.000416	CcSEcCtD
Enalapril—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000108	0.000416	CcSEcCtD
Enalapril—Somnolence—Doxorubicin—urinary bladder cancer	0.000108	0.000415	CcSEcCtD
Enalapril—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000107	0.000413	CcSEcCtD
Enalapril—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000107	0.000411	CcSEcCtD
Enalapril—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000105	0.000406	CcSEcCtD
Enalapril—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC14A2—urinary bladder cancer	0.000105	0.03	CbGpPWpGaD
Enalapril—Fatigue—Doxorubicin—urinary bladder cancer	0.000105	0.000403	CcSEcCtD
Enalapril—Urticaria—Epirubicin—urinary bladder cancer	0.000104	0.000401	CcSEcCtD
Enalapril—Constipation—Doxorubicin—urinary bladder cancer	0.000104	0.000399	CcSEcCtD
Enalapril—Body temperature increased—Epirubicin—urinary bladder cancer	0.000104	0.000399	CcSEcCtD
Enalapril—Abdominal pain—Epirubicin—urinary bladder cancer	0.000104	0.000399	CcSEcCtD
Enalapril—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000103	0.000397	CcSEcCtD
Enalapril—Asthenia—Methotrexate—urinary bladder cancer	0.0001	0.000387	CcSEcCtD
Enalapril—Feeling abnormal—Doxorubicin—urinary bladder cancer	9.99e-05	0.000385	CcSEcCtD
Enalapril—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	9.91e-05	0.000382	CcSEcCtD
Enalapril—Pruritus—Methotrexate—urinary bladder cancer	9.9e-05	0.000382	CcSEcCtD
Enalapril—Hypersensitivity—Epirubicin—urinary bladder cancer	9.65e-05	0.000372	CcSEcCtD
Enalapril—Urticaria—Doxorubicin—urinary bladder cancer	9.63e-05	0.000371	CcSEcCtD
Enalapril—Body temperature increased—Doxorubicin—urinary bladder cancer	9.58e-05	0.000369	CcSEcCtD
Enalapril—Abdominal pain—Doxorubicin—urinary bladder cancer	9.58e-05	0.000369	CcSEcCtD
Enalapril—Diarrhoea—Methotrexate—urinary bladder cancer	9.58e-05	0.000369	CcSEcCtD
Enalapril—Asthenia—Epirubicin—urinary bladder cancer	9.4e-05	0.000362	CcSEcCtD
Enalapril—Pruritus—Epirubicin—urinary bladder cancer	9.27e-05	0.000357	CcSEcCtD
Enalapril—Dizziness—Methotrexate—urinary bladder cancer	9.26e-05	0.000357	CcSEcCtD
Enalapril—Diarrhoea—Epirubicin—urinary bladder cancer	8.96e-05	0.000345	CcSEcCtD
Enalapril—Hypersensitivity—Doxorubicin—urinary bladder cancer	8.93e-05	0.000344	CcSEcCtD
Enalapril—Vomiting—Methotrexate—urinary bladder cancer	8.9e-05	0.000343	CcSEcCtD
Enalapril—Rash—Methotrexate—urinary bladder cancer	8.83e-05	0.00034	CcSEcCtD
Enalapril—Dermatitis—Methotrexate—urinary bladder cancer	8.82e-05	0.00034	CcSEcCtD
Enalapril—Headache—Methotrexate—urinary bladder cancer	8.77e-05	0.000338	CcSEcCtD
Enalapril—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC14A2—urinary bladder cancer	8.73e-05	0.025	CbGpPWpGaD
Enalapril—Asthenia—Doxorubicin—urinary bladder cancer	8.7e-05	0.000335	CcSEcCtD
Enalapril—Dizziness—Epirubicin—urinary bladder cancer	8.66e-05	0.000334	CcSEcCtD
Enalapril—CYP3A4—Estrogen metabolism—UGT2B7—urinary bladder cancer	8.62e-05	0.0247	CbGpPWpGaD
Enalapril—Pruritus—Doxorubicin—urinary bladder cancer	8.58e-05	0.00033	CcSEcCtD
Enalapril—Vomiting—Epirubicin—urinary bladder cancer	8.33e-05	0.000321	CcSEcCtD
Enalapril—Nausea—Methotrexate—urinary bladder cancer	8.31e-05	0.00032	CcSEcCtD
Enalapril—Diarrhoea—Doxorubicin—urinary bladder cancer	8.29e-05	0.00032	CcSEcCtD
Enalapril—Rash—Epirubicin—urinary bladder cancer	8.26e-05	0.000318	CcSEcCtD
Enalapril—Dermatitis—Epirubicin—urinary bladder cancer	8.25e-05	0.000318	CcSEcCtD
Enalapril—Headache—Epirubicin—urinary bladder cancer	8.21e-05	0.000316	CcSEcCtD
Enalapril—SLC22A7—Fluoropyrimidine Activity—TYMS—urinary bladder cancer	8.07e-05	0.0232	CbGpPWpGaD
Enalapril—Dizziness—Doxorubicin—urinary bladder cancer	8.02e-05	0.000309	CcSEcCtD
Enalapril—Nausea—Epirubicin—urinary bladder cancer	7.78e-05	0.0003	CcSEcCtD
Enalapril—Vomiting—Doxorubicin—urinary bladder cancer	7.71e-05	0.000297	CcSEcCtD
Enalapril—Rash—Doxorubicin—urinary bladder cancer	7.64e-05	0.000294	CcSEcCtD
Enalapril—Dermatitis—Doxorubicin—urinary bladder cancer	7.64e-05	0.000294	CcSEcCtD
Enalapril—CYP3A4—Tamoxifen metabolism—UGT2B7—urinary bladder cancer	7.62e-05	0.0219	CbGpPWpGaD
Enalapril—Headache—Doxorubicin—urinary bladder cancer	7.59e-05	0.000293	CcSEcCtD
Enalapril—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP4B1—urinary bladder cancer	7.57e-05	0.0217	CbGpPWpGaD
Enalapril—SLC22A7—Fluoropyrimidine Activity—ERCC2—urinary bladder cancer	7.5e-05	0.0215	CbGpPWpGaD
Enalapril—Nausea—Doxorubicin—urinary bladder cancer	7.2e-05	0.000277	CcSEcCtD
Enalapril—SLC22A7—Fluoropyrimidine Activity—MTHFR—urinary bladder cancer	7.05e-05	0.0202	CbGpPWpGaD
Enalapril—CYP3A4—Oxidation by Cytochrome P450—POR—urinary bladder cancer	6.18e-05	0.0177	CbGpPWpGaD
Enalapril—SLC22A7—SLC-mediated transmembrane transport—SLC14A2—urinary bladder cancer	5.65e-05	0.0162	CbGpPWpGaD
Enalapril—CYP3A4—Aflatoxin B1 metabolism—GSTM1—urinary bladder cancer	5.43e-05	0.0156	CbGpPWpGaD
Enalapril—SLC15A1—SLC-mediated transmembrane transport—SLC14A2—urinary bladder cancer	5.34e-05	0.0153	CbGpPWpGaD
Enalapril—SLC22A8—SLC-mediated transmembrane transport—SLC14A2—urinary bladder cancer	4.75e-05	0.0136	CbGpPWpGaD
Enalapril—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP4B1—urinary bladder cancer	4.66e-05	0.0134	CbGpPWpGaD
Enalapril—SLCO1A2—SLC-mediated transmembrane transport—SLC14A2—urinary bladder cancer	4.22e-05	0.0121	CbGpPWpGaD
Enalapril—ACE—Peptide hormone metabolism—IGF1—urinary bladder cancer	4.15e-05	0.0119	CbGpPWpGaD
Enalapril—SLC22A6—SLC-mediated transmembrane transport—SLC14A2—urinary bladder cancer	3.97e-05	0.0114	CbGpPWpGaD
Enalapril—ABCB1—Constitutive Androstane Receptor Pathway—SMC1A—urinary bladder cancer	3.88e-05	0.0111	CbGpPWpGaD
Enalapril—CYP3A4—Estrogen metabolism—NQO1—urinary bladder cancer	3.33e-05	0.00955	CbGpPWpGaD
Enalapril—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP4B1—urinary bladder cancer	2.96e-05	0.0085	CbGpPWpGaD
Enalapril—ACE—Metabolism of proteins—CDX2—urinary bladder cancer	2.95e-05	0.00847	CbGpPWpGaD
Enalapril—CYP3A4—Oxidation by Cytochrome P450—CYP4B1—urinary bladder cancer	2.92e-05	0.00839	CbGpPWpGaD
Enalapril—SLC22A7—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	2.87e-05	0.00824	CbGpPWpGaD
Enalapril—SLC15A1—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	2.71e-05	0.00779	CbGpPWpGaD
Enalapril—SLC22A7—Fluoropyrimidine Activity—TP53—urinary bladder cancer	2.68e-05	0.00768	CbGpPWpGaD
Enalapril—CYP3A4—Estrogen metabolism—GSTM1—urinary bladder cancer	2.55e-05	0.00732	CbGpPWpGaD
Enalapril—SLC22A8—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	2.41e-05	0.00693	CbGpPWpGaD
Enalapril—CYP3A4—Phase 1 - Functionalization of compounds—CYP4B1—urinary bladder cancer	2.4e-05	0.00689	CbGpPWpGaD
Enalapril—CYP3A4—Constitutive Androstane Receptor Pathway—SMC1A—urinary bladder cancer	2.39e-05	0.00686	CbGpPWpGaD
Enalapril—ABCB1—HIF-1-alpha transcription factor network—TFRC—urinary bladder cancer	2.15e-05	0.00618	CbGpPWpGaD
Enalapril—SLCO1A2—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	2.14e-05	0.00615	CbGpPWpGaD
Enalapril—SLC22A7—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	2.08e-05	0.00596	CbGpPWpGaD
Enalapril—SLC22A6—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	2.02e-05	0.00578	CbGpPWpGaD
Enalapril—SLC15A1—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	1.96e-05	0.00563	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	1.86e-05	0.00533	CbGpPWpGaD
Enalapril—ACE—Metabolism of proteins—IGFBP3—urinary bladder cancer	1.85e-05	0.00532	CbGpPWpGaD
Enalapril—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	1.78e-05	0.00512	CbGpPWpGaD
Enalapril—SLC22A8—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	1.75e-05	0.00501	CbGpPWpGaD
Enalapril—SLC22A7—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	1.69e-05	0.00486	CbGpPWpGaD
Enalapril—CYP3A4—Biological oxidations—GSTZ1—urinary bladder cancer	1.63e-05	0.00469	CbGpPWpGaD
Enalapril—CYP3A4—Metapathway biotransformation—GSTZ1—urinary bladder cancer	1.61e-05	0.00462	CbGpPWpGaD
Enalapril—SLC15A1—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	1.6e-05	0.00459	CbGpPWpGaD
Enalapril—SLCO1A2—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	1.55e-05	0.00445	CbGpPWpGaD
Enalapril—CYP3A4—Biological oxidations—GSTO2—urinary bladder cancer	1.55e-05	0.00444	CbGpPWpGaD
Enalapril—CYP3A4—Biological oxidations—NAT1—urinary bladder cancer	1.55e-05	0.00444	CbGpPWpGaD
Enalapril—CYP3A4—Metapathway biotransformation—GSTO2—urinary bladder cancer	1.53e-05	0.00438	CbGpPWpGaD
Enalapril—SLC22A6—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	1.46e-05	0.00418	CbGpPWpGaD
Enalapril—SLC22A8—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	1.42e-05	0.00408	CbGpPWpGaD
Enalapril—CYP3A4—Biological oxidations—UGT2B7—urinary bladder cancer	1.42e-05	0.00407	CbGpPWpGaD
Enalapril—CYP3A4—Metapathway biotransformation—UGT2B7—urinary bladder cancer	1.4e-05	0.00401	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—LIG1—urinary bladder cancer	1.33e-05	0.00381	CbGpPWpGaD
Enalapril—ABCB1—HIF-1-alpha transcription factor network—TERT—urinary bladder cancer	1.29e-05	0.0037	CbGpPWpGaD
Enalapril—CYP3A4—Biological oxidations—CYP4B1—urinary bladder cancer	1.28e-05	0.00366	CbGpPWpGaD
Enalapril—SLCO1A2—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	1.26e-05	0.00363	CbGpPWpGaD
Enalapril—CYP3A4—Metapathway biotransformation—CYP4B1—urinary bladder cancer	1.26e-05	0.00361	CbGpPWpGaD
Enalapril—SLC22A6—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	1.19e-05	0.00341	CbGpPWpGaD
Enalapril—SLC22A7—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	1.14e-05	0.00328	CbGpPWpGaD
Enalapril—ABCB1—Allograft Rejection—FAS—urinary bladder cancer	1.14e-05	0.00326	CbGpPWpGaD
Enalapril—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	1.1e-05	0.00315	CbGpPWpGaD
Enalapril—SLC15A1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	1.08e-05	0.0031	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—GSTZ1—urinary bladder cancer	1.06e-05	0.00304	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—urinary bladder cancer	1.01e-05	0.00291	CbGpPWpGaD
Enalapril—ABCB1—HIF-1-alpha transcription factor network—CREBBP—urinary bladder cancer	1.01e-05	0.00289	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—urinary bladder cancer	1.01e-05	0.00289	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—GSTO2—urinary bladder cancer	1e-05	0.00288	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—NAT1—urinary bladder cancer	1e-05	0.00288	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	9.88e-06	0.00283	CbGpPWpGaD
Enalapril—SLC22A8—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	9.61e-06	0.00276	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—UGT2B7—urinary bladder cancer	9.18e-06	0.00264	CbGpPWpGaD
Enalapril—ABCB1—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	9.18e-06	0.00263	CbGpPWpGaD
Enalapril—SLCO1A2—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	8.53e-06	0.00245	CbGpPWpGaD
Enalapril—CYP3A4—Biological oxidations—NAT2—urinary bladder cancer	8.49e-06	0.00244	CbGpPWpGaD
Enalapril—CYP3A4—Metapathway biotransformation—NAT2—urinary bladder cancer	8.37e-06	0.0024	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—CYP4B1—urinary bladder cancer	8.27e-06	0.00237	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—urinary bladder cancer	8.1e-06	0.00233	CbGpPWpGaD
Enalapril—SLC22A6—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	8.02e-06	0.0023	CbGpPWpGaD
Enalapril—ACE—Metabolism of proteins—IGF1—urinary bladder cancer	7.84e-06	0.00225	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—SLC19A1—urinary bladder cancer	7.81e-06	0.00224	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—PRSS3—urinary bladder cancer	7.61e-06	0.00218	CbGpPWpGaD
Enalapril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—urinary bladder cancer	7.59e-06	0.00218	CbGpPWpGaD
Enalapril—ABCB1—Allograft Rejection—CXCL8—urinary bladder cancer	6.93e-06	0.00199	CbGpPWpGaD
Enalapril—ABCB1—HIF-1-alpha transcription factor network—EP300—urinary bladder cancer	6.86e-06	0.00197	CbGpPWpGaD
Enalapril—CYP3A4—Biological oxidations—HPGDS—urinary bladder cancer	6.78e-06	0.00195	CbGpPWpGaD
Enalapril—ABCB1—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	6.64e-06	0.0019	CbGpPWpGaD
Enalapril—ABCB1—Allograft Rejection—IL2—urinary bladder cancer	6.62e-06	0.0019	CbGpPWpGaD
Enalapril—CYP3A4—Biological oxidations—GSTT1—urinary bladder cancer	6.58e-06	0.00189	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—urinary bladder cancer	6.44e-06	0.00185	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—urinary bladder cancer	6.33e-06	0.00182	CbGpPWpGaD
Enalapril—ACE—Metabolism of proteins—CXCL8—urinary bladder cancer	6.3e-06	0.00181	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	6.1e-06	0.00175	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—TYMP—urinary bladder cancer	6.08e-06	0.00175	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	5.84e-06	0.00168	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—urinary bladder cancer	5.61e-06	0.00161	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—NAT2—urinary bladder cancer	5.5e-06	0.00158	CbGpPWpGaD
Enalapril—ABCB1—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	5.41e-06	0.00155	CbGpPWpGaD
Enalapril—SLC22A7—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	5.35e-06	0.00154	CbGpPWpGaD
Enalapril—SLC15A1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	5.06e-06	0.00145	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	4.96e-06	0.00142	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	4.93e-06	0.00142	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	4.91e-06	0.00141	CbGpPWpGaD
Enalapril—ABCB1—Allograft Rejection—TNF—urinary bladder cancer	4.82e-06	0.00138	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—RRM2—urinary bladder cancer	4.75e-06	0.00136	CbGpPWpGaD
Enalapril—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	4.56e-06	0.00131	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—GSTZ1—urinary bladder cancer	4.53e-06	0.0013	CbGpPWpGaD
Enalapril—SLC22A8—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	4.5e-06	0.00129	CbGpPWpGaD
Enalapril—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	4.5e-06	0.00129	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—HPGDS—urinary bladder cancer	4.4e-06	0.00126	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—ENO2—urinary bladder cancer	4.4e-06	0.00126	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	4.37e-06	0.00125	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	4.31e-06	0.00124	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—GSTO2—urinary bladder cancer	4.3e-06	0.00123	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—NAT1—urinary bladder cancer	4.3e-06	0.00123	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—GSTT1—urinary bladder cancer	4.27e-06	0.00122	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	4.25e-06	0.00122	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	4.2e-06	0.00121	CbGpPWpGaD
Enalapril—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	4.19e-06	0.0012	CbGpPWpGaD
Enalapril—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	4.13e-06	0.00119	CbGpPWpGaD
Enalapril—SLCO1A2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	3.99e-06	0.00115	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—UGT2B7—urinary bladder cancer	3.93e-06	0.00113	CbGpPWpGaD
Enalapril—SLC22A6—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	3.75e-06	0.00108	CbGpPWpGaD
Enalapril—ABCB1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	3.65e-06	0.00105	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	3.61e-06	0.00104	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—NQO1—urinary bladder cancer	3.55e-06	0.00102	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—CYP4B1—urinary bladder cancer	3.54e-06	0.00102	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	3.53e-06	0.00101	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	3.44e-06	0.000987	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—SLC19A1—urinary bladder cancer	3.34e-06	0.000959	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—PRSS3—urinary bladder cancer	3.26e-06	0.000935	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	3.19e-06	0.000914	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	3.08e-06	0.000885	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	3.08e-06	0.000883	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	3e-06	0.000861	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—GSTP1—urinary bladder cancer	2.96e-06	0.000849	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	2.93e-06	0.000842	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.86e-06	0.000821	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	2.85e-06	0.000819	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	2.79e-06	0.000802	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—TYMS—urinary bladder cancer	2.75e-06	0.000789	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—NCOR1—urinary bladder cancer	2.72e-06	0.00078	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—GSTM1—urinary bladder cancer	2.72e-06	0.00078	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	2.65e-06	0.00076	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—NAT1—urinary bladder cancer	2.65e-06	0.00076	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—TYMP—urinary bladder cancer	2.6e-06	0.000747	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—GPX1—urinary bladder cancer	2.6e-06	0.000747	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	2.56e-06	0.000734	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—ERCC2—urinary bladder cancer	2.55e-06	0.000733	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	2.5e-06	0.000717	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	2.42e-06	0.000695	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—MTHFR—urinary bladder cancer	2.4e-06	0.000689	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	2.38e-06	0.000683	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	2.36e-06	0.000678	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—NAT2—urinary bladder cancer	2.36e-06	0.000676	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	2.18e-06	0.000626	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	2.1e-06	0.000602	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	2.06e-06	0.000591	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—RRM2—urinary bladder cancer	2.03e-06	0.000584	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	2.01e-06	0.000576	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—PPARG—urinary bladder cancer	1.95e-06	0.000559	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—HPGDS—urinary bladder cancer	1.88e-06	0.00054	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—ENO2—urinary bladder cancer	1.88e-06	0.00054	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—CREBBP—urinary bladder cancer	1.87e-06	0.000537	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—GSTT1—urinary bladder cancer	1.83e-06	0.000524	CbGpPWpGaD
Enalapril—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	1.71e-06	0.000491	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—TYMP—urinary bladder cancer	1.6e-06	0.000461	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—PTGS2—urinary bladder cancer	1.53e-06	0.00044	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—NQO1—urinary bladder cancer	1.52e-06	0.000436	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—NAT2—urinary bladder cancer	1.45e-06	0.000416	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—PTEN—urinary bladder cancer	1.34e-06	0.000383	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—EP300—urinary bladder cancer	1.27e-06	0.000366	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—GSTP1—urinary bladder cancer	1.27e-06	0.000363	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—RRM2—urinary bladder cancer	1.25e-06	0.00036	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—TYMS—urinary bladder cancer	1.18e-06	0.000338	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—NCOR1—urinary bladder cancer	1.16e-06	0.000334	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—GSTM1—urinary bladder cancer	1.16e-06	0.000334	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—ENO2—urinary bladder cancer	1.16e-06	0.000333	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	1.16e-06	0.000333	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	1.13e-06	0.000323	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—GPX1—urinary bladder cancer	1.11e-06	0.00032	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—ERCC2—urinary bladder cancer	1.09e-06	0.000314	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—MTHFR—urinary bladder cancer	1.03e-06	0.000295	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—NQO1—urinary bladder cancer	9.35e-07	0.000268	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—PPARG—urinary bladder cancer	8.34e-07	0.000239	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—CREBBP—urinary bladder cancer	8.01e-07	0.00023	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	7.8e-07	0.000224	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—TYMS—urinary bladder cancer	7.25e-07	0.000208	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	7.17e-07	0.000206	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	7.17e-07	0.000206	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—GPX1—urinary bladder cancer	6.86e-07	0.000197	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	6.74e-07	0.000193	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—PTGS2—urinary bladder cancer	6.56e-07	0.000188	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	6.33e-07	0.000182	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—PTEN—urinary bladder cancer	5.72e-07	0.000164	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—EP300—urinary bladder cancer	5.45e-07	0.000157	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—PPARG—urinary bladder cancer	5.14e-07	0.000147	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	4.93e-07	0.000142	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	4.04e-07	0.000116	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—PTEN—urinary bladder cancer	3.52e-07	0.000101	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—EP300—urinary bladder cancer	3.36e-07	9.64e-05	CbGpPWpGaD
